David Olvera, MD
Anesthesiology · Tyler, TXNPI 1750585337
Payments from drug & device makers
Across 336 payments — averaging $43.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Boston Scientific$4K
- Stryker$2K
- Nevro Corp.$1K
- Globus Medical$999
- Stratus Medical, LLC$623
- plus $2K from 25 others
What the payments were for
- Travel & lodging$2,40217%
- Food & beverage$11,93883%
- Education$1211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 144 | $3,868 |
| Boston Scientific | 58 | $3,560 |
| Stryker | 13 | $1,827 |
| Nevro Corp. | 23 | $1,202 |
| Globus Medical | 21 | $999 |
| Stratus Medical, LLC | 6 | $623 |
| AbbVie | 12 | $269 |
| Biotronik NRO, Inc. | 3 | $255 |
| Collegium Pharmaceutical, Inc. | 12 | $234 |
| Curonix LLC | 4 | $219 |
| Akorn, Inc. | 5 | $204 |
| Hydrocision, Inc. | 3 | $192 |
| Nalu Medical, Inc. | 3 | $163 |
| Siemens Medical Solutions USA, Inc. | 1 | $119 |
| Relievant Medsystems, Inc. | 1 | $111 |
| Medtronic(2 entities) | 2 | $110 |
| Amgen | 5 | $79 |
| Vertex | 3 | $73 |
| SPR Therapeutics, Inc | 1 | $65 |
| Impel Pharmaceuticals LLC | 2 | $47 |
| Lundbeck LLC | 2 | $44 |
| Pfizer | 2 | $39 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| Bioventus LLC | 1 | $22 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Painteq LLC | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Forte Bio-pharma LLC | 1 | $15 |
| Avanos Medical | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTABLATE$1,664
- PROCLAIM$1,244
- mild Device Kit$781
- Senza$721
- Nimbus$559
- SPINEJACK$453
- Intracept$446
- Proclaim Family of SCS IPGs$382
- GENERAL - THERAPIES$340
- Intracept RF Probe$302
- WaveWriter Alpha Prime 16$272
- GENERAL PAIN MANAGEMENT$245
- ETERNA$235
- Prospera$142
- Senza Spinal Cord Stimulation System$136
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$131
- NA$120
- Nalu Neurostimulation System$120
- Cios Flow$119
- Omnia$107
How this compares
$14,461 in reported general payments places this provider in the 95th percentile of 3,899 anesthesiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 869 | $29,574 |
| Etodolac | 249 | $16,664 |
| Xtampza ErOxycodone Myristate | 11 | $11,281 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 241 | $9,081 |
| Celecoxib | 165 | $3,370 |
| Pregabalin | 122 | $2,806 |
| Dexamethasone | 160 | $2,795 |
| Gabapentin | 195 | $2,577 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 100 | $2,517 |
| Cyclobenzaprine Hcl | 133 | $1,867 |
| Tramadol Hcl | 125 | $1,479 |
| Tizanidine Hcl | 122 | $1,240 |
| Meloxicam | 67 | $768 |
| Duloxetine Hcl | 52 | $642 |
| Diclofenac Sodium | 30 | $607 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $234 | $11,28111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,899 anesthesiology providers in Texas.
Other anesthesiology in Tyler
- Daneshvar SolankiLeague City$38M
- David BrownHouston$2.5M
- Holger EltzschigHouston$1.6M
- Julie GreeneFort Worth$1.1M
- Maria MatuszczakHouston$907K
- Ryan CaseyAustin$844K
- Richard TeamesFort Worth$746K
- Tong GanHouston$703K
- Valentine GibsonRichardson$671K
- James MuellerDallas$636K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.